VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NKTR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NKTRNektar Therapeutics
$37.26$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNKTRQuarterly Financials

Nektar Therapeutics (NKTR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Nektar Therapeutics (NKTR) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NKTR Income Statement

Quarterly statement

NKTR Income Statement

Nektar Therapeutics (NKTR) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue10.13M10.86M21.81M11.79M11.18M10.46M29.18M24.12M23.49M21.64M23.89M24.14M20.5M21.59M22.02M23.63M21.59M24.82M25.01M24.92M
Revenue Growth %-9.34%3.83%-25.25%-51.13%-52.42%-51.66%22.15%-0.08%14.59%0.21%8.45%2.2%-5.03%-13%-11.94%-5.2%-23.81%4.97%6.59%-17.02%
Cost of Goods Sold0151K0196K007.98M4.43M9.74M8.53M7.28M12.43M6.99M7.06M6.23M4.97M5.12M5.32M6.16M5.31M
COGS % of Revenue-1.39%-1.66%--27.34%18.38%41.47%39.44%30.49%51.49%34.12%32.69%28.3%21.05%23.7%21.41%24.64%21.31%
Gross Profit10.13M10.71M21.81M11.59M11.18M10.46M21.2M19.69M13.75M13.11M16.6M11.71M13.51M14.53M15.79M18.65M16.47M19.51M18.85M19.61M
Gross Margin %100%98.61%100%98.34%100%100%72.66%81.62%58.53%60.56%69.51%48.51%65.88%67.31%71.7%78.95%76.3%78.59%75.36%78.69%
Gross Profit Growth %-9.34%2.39%2.87%-41.11%-18.72%-20.18%27.68%68.1%1.81%-9.83%5.14%-37.21%-18%-25.49%-16.22%-4.88%-20.29%9.03%-1.53%-19.84%
Operating Expenses52.47M48.97M40.9M43.13M47.41M54.99M6.85M54.03M63.52M48.53M50.11M56.58M64.1M149.24M56.68M56.12M63.26M134.59M131.76M133.21M
OpEx % of Revenue517.94%450.86%187.54%365.78%424.21%525.76%23.48%223.98%270.44%224.28%209.81%234.33%312.72%691.14%257.36%237.56%293.08%542.23%526.83%534.51%
Selling, General & Admin12.77M13.29M11.38M15.87M17.07M24.35M17.14M18.96M20.51M20.15M17.32M21.15M17.87M21.08M21.94M22.53M20.52M27.34M32.14M29.47M
SG&A % of Revenue126%122.35%52.19%134.64%152.77%232.75%58.73%78.58%87.32%93.11%72.51%87.59%87.17%97.62%99.62%95.38%95.07%110.14%128.52%118.25%
Research & Development39.13M35.68M29.71M27.25M29.89M30.48M28.75M35.03M29.72M27.41M29.94M24.07M29.68M30.47M34.74M33.59M42.74M107.25M99.61M103.74M
R&D % of Revenue386.23%328.51%136.25%231.14%267.44%291.4%98.53%145.21%126.54%126.66%125.36%99.69%144.79%141.1%157.74%142.18%198.01%432.09%398.31%416.27%
Other Operating Expenses578K0-196K0447K169K-1000K46K1000K975K1000K1000K1000K1000K000000
Operating Income-42.34M-38.26M-19.09M-31.53M-36.23M-44.53M14.35M-34.34M-49.77M-35.43M-33.51M-44.86M-50.6M-134.71M-40.89M-37.47M-46.79M-115.08M-112.91M-113.6M
Operating Margin %-417.94%-352.25%-87.54%-267.45%-324.21%-425.76%49.18%-142.37%-211.9%-163.72%-140.3%-185.82%-246.84%-623.83%-185.66%-158.61%-216.78%-463.64%-451.48%-455.82%
Operating Income Growth %-16.87%14.09%-233.05%8.19%27.21%-25.71%142.82%23.45%1.63%73.7%18.04%-19.73%-8.14%-17.05%63.79%67.01%57.54%-5.2%-1.98%-10.23%
EBITDA-42.19M-38.11M-18.9M-31.34M-36.02M-44.11M14.68M-33.35M-48.31M-33.82M-31.86M-43.17M-48.43M-132.41M-38.54M-34.79M-43.35M-111.36M-110.62M-109.98M
EBITDA Margin %-416.4%-350.86%-86.67%-265.78%-322.29%-421.69%50.32%-138.25%-205.69%-156.29%-133.38%-178.8%-236.27%-613.17%-174.99%-147.28%-200.83%-448.61%-442.32%-441.3%
EBITDA Growth %-17.13%13.61%-228.75%6.04%25.46%-30.42%146.08%22.74%0.24%74.46%17.33%-24.07%-11.73%-18.91%65.16%68.36%59.36%-5.2%-2.93%-10.19%
D&A (Non-Cash Add-back)156K151K190K196K214K426K332K993K1.46M1.61M1.65M1.7M2.17M2.3M2.35M2.68M3.44M3.73M2.29M3.62M
EBIT-42.24M-36.9M-26.28M-29.51M-34M-41.4M17.16M-31.03M-45.91M-31.31M-35.24M-39.99M-45.02M-130.68M-49.34M-52.25M-151.74M-82.74M-137.52M-116.79M
Net Interest Income2.14M-3.7M-6.99M-3.23M-3.42M-2.1M-7.21M-2.58M-2.51M-1.31M-1.92M-1.03M-1.31M-2.07M-4.08M-4.9M-6.13M-7.13M-7.95M-12.67M
Interest Income9.35M4.24M2.78M2.82M1.97M2.87M2.94M3.44M3.9M4.22M4.95M4.88M4.85M4.33M3.13M2.05M1.1M395K181K131K
Interest Expense7.21M7.94M9.77M6.05M5.39M4.97M10.15M6.02M6.41M5.53M6.87M5.91M6.15M6.41M7.2M6.95M7.23M7.53M8.13M12.8M
Other Income/Expense2.04M-6.58M-16.96M-4.02M-5.55M-6.29M-7.35M-2.7M-2.54M-1.41M-8.6M-1.03M-570K-2.37M-15.65M-21.73M-112.18M24.82M-32.74M-16M
Pretax Income-40.3M-44.84M-36.05M-35.55M-41.78M-50.83M7M-37.05M-52.32M-36.84M-42.11M-45.9M-51.17M-137.08M-56.54M-59.2M-158.97M-90.27M-145.65M-129.59M
Pretax Margin %-397.8%-412.85%-165.3%-301.57%-373.88%-485.95%24%-153.57%-222.73%-170.23%-176.29%-190.1%-249.62%-634.81%-256.75%-250.6%-736.47%-363.66%-582.39%-520.02%
Income Tax2K64K31K-33K-188K52K-259K9K46K-35K-29K-61K-47K-63K3.14M-155K100K126K-4K112K
Effective Tax Rate %-0%-0.14%-0.09%0.09%0.45%-0.1%-3.7%-0.02%-0.09%0.1%0.07%0.13%0.09%0.05%-5.56%0.26%-0.06%-0.14%0%-0.09%
Net Income-40.62M-44.9M-36.08M-35.52M-41.59M-50.88M7.26M-37.06M-52.36M-36.8M-42.08M-45.84M-51.12M-137.02M-59.69M-59.05M-159.07M-90.39M-145.65M-129.71M
Net Margin %-400.97%-413.44%-165.45%-301.29%-372.2%-486.44%24.89%-153.61%-222.93%-170.07%-176.17%-189.85%-249.39%-634.52%-271.03%-249.94%-736.94%-364.16%-582.37%-520.47%
Net Income Growth %2.33%11.75%-596.89%4.14%20.57%-38.26%117.26%19.15%-2.43%73.14%29.5%22.37%67.86%-51.58%59.02%54.47%-26.73%26.49%-24.27%-19.45%
Net Income (Continuing)-40.3M-44.9M-36.08M-35.52M-41.59M-50.88M7.26M-37.06M-52.36M-36.8M-42.08M-45.84M-51.12M-137.02M-59.69M-59.05M-159.07M-90.39M-145.65M-129.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.23-1.82-1.78-1.87-2.95-3.620.51-2.66-3.76-2.83-3.30-3.61-4.05-10.95-4.80-4.65-12.75-7.35-11.85-10.50
EPS Growth %58.31%49.72%-449.02%29.7%21.54%-27.92%115.45%26.32%7.16%74.16%31.25%22.37%68.24%-48.98%59.49%55.71%-23.19%27.94%-21.54%-14.75%
EPS (Basic)-1.23-1.82-1.78-1.87-2.95-3.620.52-2.66-3.76-2.83-3.30-3.61-4.05-10.95-4.80-4.65-12.75-7.35-11.85-10.50
Diluted Shares Outstanding33.05M24.74M20.3M14.09M14.09M14.06M14.24M13.95M13.92M12.98M12.74M12.69M12.64M12.59M12.55M12.51M12.45M12.39M12.33M12.27M
Basic Shares Outstanding33.05M24.74M20.3M14.09M14.09M14.06M13.98M13.95M13.92M12.98M12.74M12.69M12.64M12.59M12.55M12.51M12.45M12.39M12.33M12.27M
Dividend Payout Ratio--------------------